Multiple Assemblies exist for SMTL entry 8qjr
BRG1 bromodomain in complex with VBC via compound 17; X-RAY DIFFRACTION 3.17 Å

SMTL ID 8qjr.1 Ligands PHOSPHATE ION; GLYCEROL; (2S,4R)-1-[(2R)-2-[3-[2-[4-[3-[4-[(1R,5S)-3-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridin-2-yl]oxycyclobutyl]oxypiperidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; Transcription activator BRG1 Oligo-state hetero-1-1-1-1-mer

SMTL ID 8qjr.2 Ligands CHLORIDE ION; PHOSPHATE ION; (2S,4R)-1-[(2R)-2-[3-[2-[4-[3-[4-[(1R,5S)-3-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridin-2-yl]oxycyclobutyl]oxypiperidin-1-yl]ethoxy]-1,2-oxazol-5-yl]-3-methyl-butanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; Transcription activator BRG1 Oligo-state hetero-1-1-1-1-mer